EP 1143978 A2 20011017 - USE OF SEX HORMONES TO OBTAIN A NASAL PHARMACEUTICAL COMPOSITION THAT IS USEFUL IN THE TREATMENT OF UNDESIRABLE UTERINE BLEEDING
Title (en)
USE OF SEX HORMONES TO OBTAIN A NASAL PHARMACEUTICAL COMPOSITION THAT IS USEFUL IN THE TREATMENT OF UNDESIRABLE UTERINE BLEEDING
Title (de)
VERWENDUNG VON SEXUALHORMONEN ZUR HERSTELLUNG EINER NASAL ANWENDBAREN PHARMAZEUTISCHEN ZUSAMMENSTELLUNG ZUR BEHANDLUNG VON UNERWÜNSCHTEN UTERINEN BLUTUNGEN
Title (fr)
UTILISATION D'HORMONES SEXUELLES POUR L'OBTENTION D'UNE COMPOSITION PHARMACEUTIQUE NASALE UTILE POUR LE TRAITEMENT DES SAIGNEMENTS UTERINS INDESIRABLES
Publication
Application
Priority
- FR 0000790 W 20000330
- FR 9904022 A 19990331
Abstract (en)
[origin: WO0059447A2] The invention relates to the use of a sex hormone to obtain a pharmaceutical composition that is suitable for nasal administration in order to treat undesirable uterine bleeding phenomena in women.
[origin: WO0059447A2] The invention relates to the use of a sex hormone (in particular estradiol on its own or with noresthisterone combined with methyl cyclodextrine) to obtain a pharmaceutical composition that is suitable for nasal administration in order to treat undesirable uterine bleeding phenomena in women.
IPC 1-7
IPC 8 full level
A61K 9/08 (2006.01); A61K 9/00 (2006.01); A61K 31/565 (2006.01); A61K 31/567 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 47/40 (2006.01); A61P 15/00 (2006.01); C07J 1/00 (2006.01)
CPC (source: EP KR)
A61K 9/0043 (2013.01 - EP); A61K 31/565 (2013.01 - EP KR); A61K 31/568 (2013.01 - EP); A61K 31/569 (2013.01 - EP); A61K 31/715 (2013.01 - EP); A61K 31/724 (2013.01 - EP); A61K 45/06 (2013.01 - EP); A61P 15/00 (2017.12 - EP)
C-Set (source: EP)
Citation (search report)
See references of WO 0059447A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0059447 A2 20001012; WO 0059447 A3 20010426; AU 3662300 A 20001023; BR 0008577 A 20021001; CA 2361885 A1 20001012; CN 1346273 A 20020424; EA 200100801 A1 20020425; EP 1143978 A2 20011017; FR 2791572 A1 20001006; HK 1044486 A1 20021025; HU P0200244 A2 20020729; HU P0200244 A3 20030528; JP 2002541076 A 20021203; KR 20010102464 A 20011115; NO 20014022 D0 20010817; NO 20014022 L 20010817; NZ 513672 A 20010928; PL 356767 A1 20040712; ZA 200106689 B 20021114
DOCDB simple family (application)
FR 0000790 W 20000330; AU 3662300 A 20000330; BR 0008577 A 20000330; CA 2361885 A 20000330; CN 00804471 A 20000330; EA 200100801 A 20000330; EP 00915247 A 20000330; FR 9904022 A 19990331; HK 02106208 A 20020823; HU P0200244 A 20000330; JP 2000609012 A 20000330; KR 20017011124 A 20010831; NO 20014022 A 20010817; NZ 51367200 A 20000330; PL 35676700 A 20000330; ZA 200106689 A 20010814